215 related articles for article (PubMed ID: 37378783)
21. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
[TBL] [Abstract][Full Text] [Related]
22. Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility.
Kashour T; Halwani R; Arabi YM; Sohail MR; O'Horo JC; Badley AD; Tleyjeh IM
Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):37-50. PubMed ID: 33406943
[TBL] [Abstract][Full Text] [Related]
23. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
24. Effects of statins on myocarditis: A review of underlying molecular mechanisms.
Parsamanesh N; Karami-Zarandi M; Banach M; Penson PE; Sahebkar A
Prog Cardiovasc Dis; 2021; 67():53-64. PubMed ID: 33621589
[TBL] [Abstract][Full Text] [Related]
25. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
Conti P; Ronconi G; Caraffa A; Gallenga CE; Ross R; Frydas I; Kritas SK
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):327-331. PubMed ID: 32171193
[TBL] [Abstract][Full Text] [Related]
26. Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
Barkas F; Milionis H; Anastasiou G; Liberopoulos E
Med Hypotheses; 2021 Jan; 146():110452. PubMed ID: 33333472
[TBL] [Abstract][Full Text] [Related]
27. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
28. Role of Toll-like receptors in the pathogenesis of COVID-19.
Khanmohammadi S; Rezaei N
J Med Virol; 2021 May; 93(5):2735-2739. PubMed ID: 33506952
[TBL] [Abstract][Full Text] [Related]
29. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
30. Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage.
Ashraf U; Ding Z; Deng S; Ye J; Cao S; Chen Z
Virulence; 2021 Dec; 12(1):968-980. PubMed ID: 33724154
[TBL] [Abstract][Full Text] [Related]
31. Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade.
Bahmani M; Chegini R; Ghanbari E; Sheykhsaran E; Shiri Aghbash P; Leylabadlo HE; Moradian E; Kazemzadeh Houjaghan AM; Bannazadeh Baghi H
World J Virol; 2022 May; 11(3):113-128. PubMed ID: 35665236
[TBL] [Abstract][Full Text] [Related]
32. Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases.
Lashgari NA; Roudsari NM; Zadeh SST; Momtaz S; Abbasifard M; Reiner Ž; Abdolghaffari AH; Sahebkar A
Inflammopharmacology; 2023 Feb; 31(1):57-75. PubMed ID: 36574095
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones.
Turner NA; Mughal RS; Warburton P; O'Regan DJ; Ball SG; Porter KE
Cardiovasc Res; 2007 Oct; 76(1):81-90. PubMed ID: 17612514
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
35. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.
Cai J; Wang YL; Sheng XD; Zhang L; Lv X
J Ethnopharmacol; 2022 Nov; 298():115661. PubMed ID: 36002086
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
37. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
[TBL] [Abstract][Full Text] [Related]
38. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
Xiang J; Lu M; Shi M; Cheng X; Kwakwa KA; Davis JL; Su X; Bakewell SJ; Zhang Y; Fontana F; Xu Y; Veis DJ; DiPersio JF; Ratner L; Sanderson RD; Noseda A; Mollah S; Li J; Weilbaecher KN
J Virol; 2022 Apr; 96(7):e0005722. PubMed ID: 35319225
[TBL] [Abstract][Full Text] [Related]
39. Association of statins with inflammatory cytokines: a population-based Colaus study.
Lyngdoh T; Vollenweider P; Waeber G; Marques-Vidal P
Atherosclerosis; 2011 Nov; 219(1):253-8. PubMed ID: 21855068
[TBL] [Abstract][Full Text] [Related]
40. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
